MRNA Income Statement
Moderna Inc - Revenue, Expenses & Profit Analysis
Stock Price
$79.76
Market Cap
$24.52B
Most Recent Quarter
Period: FY(2025-12-31)
Revenue
Total sales from operations
$1.94B
-39.9% YoY
Cost of Revenue
Direct costs of sales
$868.00M
Gross Profit
Revenue - Cost of Revenue
$1.08B
Operating Income
Gross Profit - Operating Expenses
$-3.07B
Net Income
Bottom line profit
$-2.82B
Margin: -143.5%
Earnings Per Share (Diluted)
Net income per share
$-7.26
Profitability Metrics
Net Margin
-143.5%
Historical Income Statements
| Period | Revenue | Gross Profit | Operating Income | Net Income | EPS |
|---|---|---|---|---|---|
| FY | $1.94B | $1.08B | $-3.07B | $-2.82B | $-7.26 |
| 2024-12-31 | $3.24B | - | - | $-3.56B | $-9.28 |
| FY | $3.24B | $1.77B | $-3.94B | $-3.56B | $-9.28 |
| 2023-12-31 | $6.85B | - | - | $-4.71B | $-12.33 |
| FY | $6.85B | $2.15B | $-4.24B | $-4.71B | $-12.33 |
View Complete Financial Analysis
Full income statements, balance sheets, cash flows, and AI-powered insights
Open Full AnalysisFrequently Asked Questions
What is MRNA's revenue?
MRNA's most recent quarterly revenue was $1.94B, representing a decline of 39.9% year-over-year.
Is MRNA profitable?
MRNA reported a loss of $2.82B in the most recent quarter. The net profit margin is -143.5%.
What is MRNA's operating income?
MRNA's operating income was $-3.07B in the most recent quarter.
What is MRNA's earnings per share (EPS)?
MRNA reported diluted earnings per share of $-7.26 in the most recent quarter.
What is MRNA's gross profit margin?
Gross margin data is available in the profitability metrics section.